NASDAQ · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · SMALL CAP
Edap TMS SA FOCL
17 fiscal years on record · EUR · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
€70.5M
▲ 1.6% vs FY2024
EPS · FY25
€-0.78
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-94.5%
Net margin · FY25
-41.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
EUR 70.5M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 41 cents on every revenue dollar this year.
Per share
EUR -0.78
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-94.5%
Return on equity, FY2025
ROE
Operating margin-35.0%
Net margin-41.5%
Return on assets-34.7%
Each EUR of equity lost 94 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+11.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+8.6%
+11.1%
+8.1%
+7.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.04B
Shares outstanding, FY2025
Change, 5 years+28.5%
Change, 10 years+47.7%
The share count grew 29% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
EUR 79.0M
total assets, end of FY2025
Total assetsEUR 79.0M
EquityEUR 19.4M
CashEUR 20.5M
Gross debtEUR 18.0M
Net debtEUR -2.4M
Current ratio1.54×
The company holds more cash than debt.
History
17 fiscal years
Every figure from documents filed with the SEC · EUR
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue €B
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income €B
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA €B
−0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax €B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income €B
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted €
−0.78
−0.55
−0.57
−0.09
0.02
−0.06
0.05
−0.01
−0.02
0.13
−0.07
−0.02
−0.24
−0.43
−0.07
−0.98
·
Dividend / sh €
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−94.5
−39.1
−31.5
−4.8
1.8
−6.4
5.8
−1.3
−2.7
19.8
−11.3
−4.2
−57.6
−88.6
−10.7
−118.4
−61.7
Shares out B
0.04
0.04
0.04
0.04
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.02
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
65 of 65
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed